The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
diphenhydramine citrate and ibuprofen · DIPHENHYDRAMINE CITRATE 38 mg/1; IBUPROFEN 200 mg/1 · Tablet, Coated · Oral · Haleon US Holdings LLC
NDC 00573-0164-04 · 4 TABLET, COATED in 1 POUCH · NDA · View full market →
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Not scored — fragility is computed for NADAC-priced NDCs.
sole-source market · price up 4% YoY
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
No FDA shortage reports for this drug or its presentations.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Haleon US Holdings LLC | DIPHENHYDRAMINE CITRATE 38 mg/1; IBUPROFEN 200 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Select Consumer Group | DIPHENHYDRAMINE CITRATE 38 mg/1; IBUPROFEN 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Advil Pm — NDC 00573-0164-04," retrieved September 3, 2026, https://drugdashboards.com/drug/00573016404.
Free to cite with attribution — see how the data is put together.